VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. in Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9, 2022 and April 1, 2024, both dates inclusive (the "Class Period")....
How humble cells in a little-known organ manage brain inflammation
The choroid plexus with infiltrating white blood cells following a brain bacterial infection. Credit: Huixin Xu/Boston Children’s HospitalDeep in the brain, sheets of tissue known as the choroid plexus produce cerebrospinal fluid (CSF) and act as a protective barrier...
Tern Therapeutics Launches with Batten Disease Gene Therapy Programs
Tern Therapeutics, a new biotech startup, officially launched on August 27, 2024, with $15 million in funding to advance gene therapies targeting Batten disease, specifically the ceroid lipofuscinosis type 2 (CLN2) form. This neurodegenerative disorder leads to vision...
Multipurpose vaccine shows new promise in the presence of pre-existing immunity
Graphical abstract. Credit: Cell (2024). DOI: 10.1016/j.cell.2024.07.052As researchers estimate that nearly all Americans have been exposed to SARS-CoV-2, the virus that causes COVID-19, whether through infection or vaccination, we are no longer "immunologically...
Vaccine shows promise in treating high blood sugar for those with long COVID
SARS-CoV-2 infection of AGM reflects virologic, and immune response reported in humans. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-50339-4Researchers at Tulane University have discovered a new approach to tackling a lingering health challenge faced...
Biopharma companies, BARDA call for more clarity on FDA’s new platform tech proposal
Following the FDA’s May release of long-awaited draft guidance explaining how companies can win designations for certain cell and gene therapy “platform” technologies, companies like Regeneron, Alnylam, Verve Therapeutics and others are seeking more clarity from the...
Advancing Gene Therapy for Gaucher Disease: AAV-Mediated Delivery of a Thermostable Glucocerebrosidase Variant Shows Promising Results in Preclinical Models
Recent research has explored the potential of a modified adeno-associated virus (AAV) vector to deliver a thermostable variant of the glucocerebrosidase (GCase) enzyme in a mouse model of (GD), specifically the type 3 neurological subtype. Gaucher disease, a lysosomal...
AIR Awarded $28 Million Contract to Enhance Accessibility of Cell and Gene Therapy for Medicaid Recipients
Arlington, Va., Aug. 21, 2024– The American Institutes for Research (AIR) has been awarded a significant federal contract by the Center for Medicare and Medicaid Innovation (CMMI) under the Centers for Medicare and Medicaid Services (CMS) to assist in the...
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to Better Protect Against Currently Circulating Variants
SILVER SPRING, Md., Aug. 22, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to...
Versant and Novartis build ‘Chinook 2.0’ for RNA therapies in kidney diseases
Five years to the day after launching Chinook Therapeutics, Versant Ventures is back with a second generation of that kidney disease biotech and has a partner in Chinook’s acquirer, Novartis. The biotech incubator and investor broke the cover on Vancouver startup...
CDC and local experts anticipate new fall COVID vaccines in September
As COVID-19 settles into a permanent presence in our lives, annual vaccinations are becoming the norm. Earlier this month, an official from the Centers for Disease Control and Prevention (CDC) declared COVID-19 "endemic," indicating that the virus is here to stay. As...
Everest Medicines Announces the Initiation of an Investigator-Initiated Clinical Trial (IIT) for Personalized mRNA Cancer Vaccine Program EVM16
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced the launch of an Investigator-Initiated Clinical...
Popular Services
AAV Packaging Service
AAV Analytical Service
Vector Design